Expression of the matrix metalloproteinase (MMP) gene stromelysin-3 (ST3) has been shown to be tightly associated with cell migration and apoptosis in mammals and amphibians. This contrasts with most other MMP genes. We demonstrate here that the Xenopus ST3 gene also has a structure distinct from other MMP genes, with its C-terminal half (the hemopexin domain) encoded by 4 instead of 6 exons, as in other MMP genes. Our primer extension analysis reveals the existence of two transcription start sites and at least one is needed for transcription of the promoter in transient transfection assays. Furthermore, our deletion analysis has demonstrated a requirement for at least one GAGA factor binding site for promoter function. In vitro DNA binding and mutational studies have provided strong evidence for the participation of GAGA or GAGA-like factors in transcriptional regulation of the frog ST3 gene. This contrasts with regulation of the human ST3 promoter. These results suggest that the ST3 gene evolved prior to most other metalloproteinase genes and uses distinct regulation pathways to achieve similar expression profiles and serve similar functions in mammals and amphibians.
INTRODUCTION
Matrix metalloproteinases (MMPs) are a family of Zn 2+ binding extracellular proteases (1) (2) (3) (4) . In general, they are synthesized as pre-enzymes and are secreted into the extracellular matrix (ECM) or inserted into the plasma membrane as pro-enzymes upon the proteolytic removal of the prepeptide (see also 5). The pro-enzymes are enzymatically inactive due to the formation of a fourth coordination bond with the catalytic Zn 2+ ion by the conserved cysteine residue in the propeptide (4, (6) (7) (8) (9) . Upon cleavage of the propeptide, mature MMPs are produced, which can degrade various components of the ECM.
The ECM is composed of many proteins and non-proteinaceous components, which form a complex networked structure (10) . The ECM serves as a structural support medium for the cells it surrounds. More importantly, the interaction between the cell and various components of the ECM is a dynamic one which influences cell shape, cell metabolism and, ultimately, cell fate. Some examples of cell behavior affected by ECM include cell migration, cell proliferation and differentiation and apoptosis or programed cell death (10) (11) (12) . Thus, the degradation or remodeling of the ECM through the digestion, by MMPs, of different proteinous ECM components, including collagen, fibronectin, laminin, entactin, etc. (10), will influence cell behavior during normal and pathological processes. Such ECM remodeling can be regulated through the modulation of MMP activities. Indeed, a number of MMP genes are known to be up-regulated during many developmental processes and tumor progression when cancerous cells undergo metastasis, a process that requires extensive degradation of the ECM to allow the cancerous cells to spread into different host tissues (3, (13) (14) (15) (16) (17) .
We are studying the roles of MMPs during post-embryonic vertebrate development using Xenopus laevis metamorphosis as a model. Amphibian metamorphosis involves systematic transformations of different organs of the tadpole (18, 19) . These include the complete resorption of larval-specific organs, such as the tail, de novo development of adult organs, like the limb, and drastic remodeling of organs that are present both in the tadpole and frog. Extensive ECM degradation and remodeling occur as larval tissues degenerate and adult tissue morphogensis takes place (20) . Consistently, we and others have found that several MMPs are activated during metamorphosis (21) (22) (23) (24) (25) (26) . In particular, the MMP stromelysin-3 (ST3) has been shown to be associated with apoptosis and ECM remodeling (22) (23) (24) . Furthermore, the ST3 gene can be precociously activated upon induction of precocious metamorphosis in pre-metamorphic tadpoles with exogenous thyroid hormone (24, 26) , the causative agent of amphibian metamorphosis (18, 19) .
Toward a better understanding of transcriptional regulation of the X.laevis ST3 gene, we have determined its genomic organization and promoter structure. We have found that the ST3 gene has a unique intron-exon organization compared with other members of the MMP family. We further demonstrate the existence of two adjacent transcription start sites and a GAGA-like transcription factor(s) involved in the regulation of the expression of the Xenopus ST3 gene.
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MATERIALS AND METHODS

RNA isolation and northern blot analysis
Tadpoles of indicated stages (27) were treated with or without 5 nM T 3 (Sigma) in the rearing water. RNA isolation and northern blotting were carried out as described (28, 29) using a X.laevis ST3 cDNA fragment (24) .
To control for RNA loading and quality, the northern blots were stained with methylene blue before hybridization (30) .
Isolation and characterization of genomic clones
A λ genomic library of homozygous X.laevis DNA was screened with a ST3 cDNA probe as described (24, 31) . Positive clones were isolated after secondary and tertiary screening. The intron-exon boundaries were determined by direct sequencing of the inserts in λ DNA using end-labeled exon-specific primers (32) . The intron sizes were determined by PCR as described (31) .
Primer extension to map the transcription start site
Twenty micrograms of total RNA from stage 62 tadpoles (metamorphic climax) and stage 66 frogs (the end of metamorphosis) (27) were annealed with 1 µg 32 P-labeled primer (5′-TACATAAGTCTTTTCCCTGTGAGTC-3′, at +110 to +86) in 10 µl 1× annealing buffer (20 mM Tris-HCl, pH 8.3, 0.4 M KCl) by incubating sequentially at 65_C for 10 min, 55_C for 25 min and then 45_C for 10 min. The mixture was then mixed with 4 µl 10× reverse transcription buffer (0.5 M Tris-HCl, pH 8.3, 60 mM MgCl 2 ), 1 µl 25 mM dNTP mixture, 0.1 µl RNase inhibitor (Life Technologies Inc.), 1 µl 0.1 M DTT, 1 µl 1 µg/µl actinomycin D (Sigma), 1/6 µl Superscript II reverse transcripts (Life Technologies Inc.) and 23 µl H 2 O. The extension reaction was then carried out by incubating the mixture at 42_C for 1.5 h. The product was ethanol precipitated and analyzed on a sequencing gel together with a sequencing size ladder made with the same primer.
Construction of ST3 promotor plasmids
Promoter fragments were cloned into a promoter-less luciferase reporter, pGL Basic vector (Promega). First, a 1.6 kb HindIII fragment encoding the region from -985 to approximately +600 was isolated from a genomic clone and ligated into HindIII-digested pBluescript KS(-) to generate the plasmid ST3gl8h. ST3gl8h was then digested with HindIII and BSSHII and the 1 kb 5′-fragment (-985 to +25) was ligated into the BglII-digested pGL Basic vector through blunt-end ligation to produce the promoter construct IU25-pGL. To generate a 5′-deletion construct, a promoter fragment was amplified by PCR from IU25-pGL by using one primer located downstream of the multiple cloning linker of the pGL Basic vector (5′-CTC TAG AGG ATA GAA TGG-3′) and another primer that was attached with a KpnI restriction site at its 5′-end and located at an appropriate position upstream in the promoter region to produce the desired deletion. The amplified DNA was digested with KpnI and HindIII and cloned into pGL Basic. A similar approach was used to generate 3′ deletion constructs with the use of one primer located upstream of the multiple cloning linker of pGL Basic (5′-TGT CCA AAC TCA TCA ATG TA-3′).
To construct a promoter with both 5′ and 3′ deletions, IU25-pGL was PCR amplified with an upstream primer bearing a KpnI site and a downstream primer bearing a HindIII site. To generate constructs with the 3′-end located downstream of +25, the plasmid ST3gl8h was used as the template for PCR.
To produce a promoter with an internal deletion or mutation, two overlapping fragments were PCR amplified. The first one was made using one primer bearing the desired changes in the middle and 10-15 non-mutated bases on both sides and an upstream primer for the desired 5′ boundary. The second fragment was made using a primer that is complementary to the mutated primer used in the first PCR fragment and a downstream primer for the desired 3′ boundary. Aliquots of the two amplified fragments were mixed and re-amplified using only the upstream and downstream primers. The overlap between the two fragments in the mutated primer region allowed amplification of a larger fragment containing the desired mutation. This large fragment was then cloned as above.
Culturing of X.laevis cell lines
Xenopus laevis tissue culture cell lines XL2 (33), A6 (34), XL58 (derived from Xenopus embryos, a gift from Dr R.Roeder) and XL177 (35) were grown in 67% Leibovitz L15 medium containing 10% fetal calf serum (Life Technologies Inc.). Cells were plated at ∼0.5-3 × 10 6 /25 cm 2 flask and cultured at 25_C in capped flasks. Two days after plating, cells were washed with serum-free medium before adition of medium containing 10% serum that had been treated with AG1-X8 resin (Bio-Rad) to remove thyroid hormone and treated with 20 nM T 3 or a control solution (29) . Twenty-four hours after treatment, total RNA was isolated from the cells using RNAzol (Tel-Test Inc.) and quantified by absorption at 260 nm.
Transient transfections
Transfections were done using 1 µg plasmid and 25 µl Lipofectin (Life Technologies Inc.) and 2 × 10 6 cells/25 cm 2 flask as described (29) . After overnight culture at 25_C, medium containing 20% T 3 -depleted serum (above) was added. One day later, T 3 (to a final concentration of 50 nM) or a control solution was added and the cells were incubated for another 24 h before extracts were made for luciferase assay according to the manufacturer's instructions (Analytical Luminescence Laboratory, Ann Arbor, MI).
Gel mobility shift assay
One nanogram of 32 P-labeled double-stranded oligonucleotides containing putative GAGA factor binding sites was mixed with 25 ng recombinant Drosophila GAGA factor (a kind gift of Drs T.Tsukiyama and C.Wu; 36) or 9 µg whole cell extract made from XL58 cells according to Ranjan et al. (29) in 20 µl 1× binding buffer (25 mM HEPES, pH 7.6, 0.5 mM EDTA, 12.5 mM MgCl 2 , 10% glycerol, 1 mM DTT and 125 mM KCl) containing 1 µg poly(dI·dC) and 20 µg bovine serum albumin and the mixture was incubated at room temperature for 30 min. The binding reaction products were analyzed directly on a 5% polyacrylamide gel (0.5× TBE) at room temperature (36) . The double-stranded oligonucleotides used included: DE (made from 5′-GGG AGA GAG AGA GAG AGA GAG AGA AGT AC-3′ and 5′-TTC TCT CTC TCT CTC TCT CTC TCC CGT A-3′); FG (made from 5′-ACA AAA GGC AGA GAG GAG TAG TAC-3′ and 5′-TAC TCC TCT CTG CCT TTT GTG TAC-3′); HI (made from 5′-CAG GGA GAG AGC CAG AGC CAG TAC-3′ and 5′-TGG CTC TGG CTC TCT CCC TGG TAC-3′); mDE (made from 5′-GGG AGT GCA AGT CAT AGC GTT AGT AGT AC-3′ and 5′-TAC TAA CGC TAT GAC TTG CAC TCC CGT AC-3′).
RESULTS
Genomic organization of the X.laevis stromelysin-3 gene
Using a cDNA fragment of the X.laevis stromelysin-3 (ST3) gene as a probe, we screened a λ library made of genomic DNA from homozygous X.leavis and obtained several genomic ST3 clones. Hybridization using primers specific to the 5′-and 3′-regions of the full-length ST3 cDNA sequence (24) identified one genomic clone that contained the entire ST3 gene. This clone was used for further characterization.
To determine the intron-exon boundary of the ST3 gene, a series of sense and antisense primers were made along the ST3 cDNA sequence and used to sequence the full-length λ genomic clone directly using a PCR-based protocol (32) . The results showed that Xenopus ST3 is organized into 8 exons (Fig. 1) . Each of the exons encodes part of the coding region. All of the exons are <300 bp in length except the last exon, which encodes the last 47 amino acids and the entire 3′-UTR of ∼1200 bp. The prepeptide is encoded by exon 1 and the propeptide by exons 1 and 2. The catalytic domain is split into four exons, with the N-terminal portion in exon 2. The hemopexin domain is also encoded by four exons, with exon 5 containing the C-terminal end of the catalytic domain and the N-terminal end of the hemopexin domain. Thus, their intron-exon boundaries are not organized in an exact manner to separate the different domains of the proteins.
PCR analysis showed that the sizes of the introns range from 80 to 3400 bp ( Fig. 1 ) and the entire ST3 mRNA is encoded by ∼10.5 kb of genomic DNA.
Two transcription start sites are present in the Xenopus ST3 gene
To determine the transcription start site, a 32 P-labeled antisense primer located in the first exon was used in the primer extension reaction with RNA isolated from tadpoles at stages 62 and 66. These two tadpole stages were chosen because stage 62 is the climax of metamorphosis and is a stage when ST3 mRNA is highly expressed, while stage 66 is the end of metamorphosis and has little ST3 mRNA (24) . Analysis of the primer extension products on a sequencing gel revealed the presence of two products of different lengths (Fig. 2B) . The primer extension products were present when stage 62 tadpole RNA was used, but not when stage 66 tadpole RNA was used, just like the ST3 mRNA (24) . These results indicate that the products were derived specifically from the ST3 mRNA and thus two transcription start sites exist for the ST3 gene. The minor one is labeled as the +1 position and the major one as the -94 position (Fig. 2A) . The previously cloned ST3 cDNA begins with the A residue at -27 (24), suggesting that it was derived from an mRNA initiated from the major start site.
Sequence analysis of the promoter region up to -985 revealed the presence of a consensus TATA box at -32 to -27 and 11 GA dinucleotide repeats at -50 to -72, implying the existence of a site recognized by the GAGA transcription factor ( Fig. 2A; 37 ). In addition, another potential TATA box (-87 to -82) and two other putative GAGA factor binding sites (-41 to -36 and +50 to +56) are also present near the start sites ( Fig. 2A) .
Functional characterization of the ST3 promoter and promoter mutants
To determine the sequence important for ST3 expression, we employed a transient transfection assay with the ST3 promoter fused to the luciferase reporter gene. Several X.laevis cell lines are available for transfection studies. We first analyzed expression of the endogenous ST3 gene in these cell lines, including XL2, A6, XL58 and XL177, with or without a 1 day treatment with T 3 , which is known to up-regulate ST3 expression when added to the rearing water of pre-metamorphic tadpoles (e.g. at stage 56; Fig. 3;  24) . Northern blot hybridization revealed that ST3 could be induced by T 3 in XL58 and XL177 cells but not in XL2 or A6 cells (Fig. 3) . Although the mRNA levels in the tissue culture cells were much lower than that in pre-metamorphic tadpoles after T 3 treatment, the results showed that both XL58 and XL177 cells expressed all the factors necessary for expression of the ST3 gene and its up-regulation by T 3 . We chose XL58 cells for our transfection studies, as they grow faster and appear to have a higher transfection efficiency under our conditions.
Initial transfection studies with a 1 (-985 to +25) or 4 kb promoter construct (approximately -4000, the upstream EcoRI site, to +25; Fig. 1A) showed that both promoter constructs could drive expression of the luciferase reporter with similar efficiencies, (A) Sequence of the ST3 promoter region and the first exon. The major and minor transcription start sites are marked by the large and small arrowheads respectively. The minor start site is labeled as +1. The star indicates the 5′-end of the λ cDNA clone encoding the full-length ST3 reported previously (24) . A consensus TATA box and a putative TATA box are boxed and putative GAGA factor binding sites are underlined. (B) Primer extension revealed two start sites. Total RNA from tadpoles at stages 62 and 66 was used and the sequencing ladder was obtained using the same primer to sequence a genomic subclone. The small and large arrowheads indicate the minor and major transcription start sites. Note that in agreement with the northern blot analysis (24), ST3 mRNA was present in stage 62 tadpoles but not or at very low levels in stage 66 tadpoles (it is possible that part of the signal detected in the stage 66 lane was due to carry-over from the stage 62 lane). but with little effect (<2-fold) of T 3 treatment (up to 100 nM; data not shown). In addition, a construct from -986 to approximately +600 (the HindIII fragment encompassing the promoter region; Fig. 1A ) also failed to show a significant response to T 3 (data not shown). These results suggest either that the T 3 response element(s) (TRE) in the ST3 gene is located upstream of -4000 or downstream of +600 or that the ST3 gene is not a direct T 3 response gene, despite the apparent resistance of its up-regulation by T 3 treatment to protein synthesis inhibition (26) . Therefore, the studies here focused on characterization of the DNA elements that are responsible for T 3 -independent expression of ST3.
A series of deletion constructs of the promoter were made from both the 5′-(starting at -985) and 3′-ends (starting at +25). Transient transfection assay of luciferase reporter expression showed that 5′ deletion of the first 550 bp had little effect on promoter activity (Fig. 4A) . Further deletion of another 150 bp (to -282) produced a slightly more active promoter, suggesting the possible existence of an inhibitory element between -432 and -282. Interestingly, continued deletion to -83, which removed the major start site at -94 and the putative TATA box at -87 to -82, also had little effect on promoter function. On the other hand, deletion to -33, which removed the major start site at -94 as well as the GA repeats at -72 to -50 and -41 to -36, abolished promoter function (Fig. 4A) . Thus, the putative GAGA factor binding site at -72 to -50 and/or -41 to -36 is critical for the ST3 promoter.
Deletion from the 3′-end to -9, which removed the region around the minor start site, also did not have a major effect on the promoter (Fig. 4B) . On the other hand, a deletion construct that had both the major and minor start sites removed (construct pGL16, -83 to -9) has <10% of the activity of the full-length promoter (Fig. 4B ), even though it had the putative GAGA binding sites and TATA box. Thus, at least one start site is required for the promoter to function. Further 3′ deletion to -33, which removed the start site at +1 and the consensus TATA box, showed that the TATA box is not critical for promoter activity (Fig. 4B) . Continued deletion (to -44) to remove the putative GAGA factor binding site at -41 to -36 appeared to decrease the promoter activity by ∼2-fold. Finally, 3′ deletion to -84, which removed the putative GAGA factor binding sites, abolished promoter function despite the presence of the upstream start site (Fig. 4B) . Thus, the 5′ and 3′ deletions showed that the GAGA factor binding sites and at least one of the start sites are required for the promoter to function, while the putative TATA boxes are not important.
To further test the role of the GAGA factor binding sites and TATA boxes, site-directed mutations or deletions were performed. Removal of the long GA repeat (at -72 to -50) resulted in a 4-fold reduction in promoter activity and further removal of the second GA repeat (at -41 to -38) led to an additional 2-fold reduction in activity (Fig. 4C) . On the other hand, mutating the consensus TATA box or both putative TATA boxes had little effect on promoter function. These results confirmed the conclusions from the deletion studies above.
Sequence analysis of the promoter region also revealed the existence of a putative GAGA factor binding site at +50 to +56 (Fig. 2A) . To test whether this element can influence promoter Figure 5 . The Drosophila GAGA factor can bind to the long GAGA repeat in the ST3 promoter. A 32 P-labeled double-stranded oliggonucleotide (DE) encompassing the long GA repeat at -72 to -50 was mixed with purified recombinant Drosophia GAGA factor, in the presence or absence of the indicated unlabeled oligonucleotides. The resulting mixture was then analyzed on a non-denaturing polyacrylamide gel. FG and HI were double-stranded oligonucleotides containing the GA repeats at -41 to -36 and +50 to +56 respectively. NS1 and NS2 were two non-specific oligonucleotides containing no GAGA repeats.
function, a construct including -432 to +98 was made and found to have only a modestly higher level of activity than the construct from -432 to +25, suggesting that this downstream GA repeat adds little to promoter activity when the other two GA repeats are present. On the other hand, the construct from -33 to +97 had nearly 10% of the activity of the full-length promoter (Fig. 4C) . However, construct -33 to +25, which had no GA repeat at all, had only 2% of the activity of the full-length promoter (Fig. 4A) . It is also interesting to note that the construct from -83 to -9 ( Fig. 4B) , which, like the one from -33 to +98 had only one GA repeat (at -41 to -36) and the start site at +1, had similar activity to that from -33 to +98. Thus, the putative GAGA binding site at -41 to -36 and that at +50 to +56 had similar activities, in agreement with their similar sequences, i.e. (GA) [2] [3] (Fig. 2A) .
Binding of the GA repeats by GAGA factor in vitro
The requirement for the putative GAGA factor binding sites, especially the one located at -72 to -50, for ST3 promoter function implicates the involvement of GAGA factor in transcription of the promoter. To directly test whether these GA repeat sequences are GAGA factor binding sites, we synthesized complementary oligonucleotides covering these GA repeats and tested their ability to bind to the recombinant Drosophila GAGA factor in vitro. Gel mobility shift assay showed that the double-stranded oligonucleotide DE, which encompassed the long GA repeat at -72 to -50, bound to the GAGA factor strongly (Fig. 5) . On the other hand, oligonucletides FG and HI, which encompassed the GA sequence at -41 to -36 and -50 to +56 respectively, failed to show detectable binding under our conditions (data not shown). Consistently, competition experiments using 32 P-labeled DE and unlabeled DE, FG or HI showed that a 100-fold excess of DE could efficiently compete binding by labeled DE, while similar levels of FG and HI showed only very weak competition (Fig. 5) . Two unrelated double-stranded oligonucleotides (NS1 and NS2) failed to compete for complex formation. These results, together Figure 6 . GAGA or GAGA-like factors are present in XL58 cells. (A) 32 P-Labeled DE, FG or HI were mixed with no protein (-), Drosophila GAGA factor (GAGA) or XL58 cell protein extract (Extract) and the resulting complexes were analyzed on a non-denaturing gel. Note that two (for FG and HI) and three (for DE) complexes were formed with the cell extract. The faster migrating one that was present with all probes has a similar mobility to the complexes formed by DE and Drosophila GAGA factor. (B) Specific competition of the complexes formed between 32 P-labeled DE and the cell extract by increasing concentrations (10, 25 and 100 ng) of unlabeled DE but not by FG, HI or a non-specific DNA (NS2). The control lane shows probe alone and the -lane had no competitor. The arrow points to the complex with similar mobility to the complex formed by DE and Drosophila GAGA factor. with the dose dependence of competition (not shown), showed that the long GA repeat at -72 to -50 (DE) is a strong GAGA factor binding site, while the other two short GA repeats (FG and HI) are at best weak GAGA factor binding sites.
To determine whether the GAGA factor or related factors are present in X.laevis, especially in XL58 cells, whole cell extracts were prepared from XL58 cells and used for gel mobility shift assays with 32 P-labeled DE, FG and HI (Fig. 6A) . All three double-stranded oligonucleotides could form two major complexes with the XL58 cell extract (Fig. 6A) . A third, fast migrating complex was also formed with the DE oligonucleotide. The faster migrating of the two complexes formed with all three DNAs had similar mobility to the complex formed between DE and the Drosophila GAGA factor (Fig. 6A) . The complexes formed with 32 P-labeled DE could again be efficiently competed away by unlabeled DE, but not by FG, HI or an unrelated sequence (NS2, Fig. 6B ). Thus, although we do not know the exact identities of the proteins in these complexes, the specificity of complex formation and specific competition suggest that GAGA or GAGA-like factors are present in XL58 cells.
A further confirmation for the specificity of complex formation was obtained using a mutant oligonucleotide of DE (mDE). Again, unlabeled DE could efficiently compete for complex formation by labeled DE with the Drosophila GAGA factor (Fig. 7A ) or XL58 cell extract (Fig. 7B) . On the other hand, mDE failed to compete in both cases. Thus, the complexes are specific for GAGA or GAGA-related factors.
DISCUSSION
Xenopus ST3 was initially isolated as a gene regulated during amphibian metamorphosis (26) . Toward understanding its regulation, we have demonstrated here that the ST3 gene is organized into eight exons and has two transcription start sites. We further show that its transcription appears to require the participation of GAGA or GAGA-like factors.
ST3 has a unique intron/exon organization compared with other MMPs
ST3 belongs to the growing family of matrix metalloproteinases (MMPs), which can degrade various components of the ECM. ST3 was initially identified as an MMP specifically expressed in breast cancer carcinomas (38) . During normal development, ST3 is expressed where cell death or apoptosis takes place in mammals (38, 39) . Similarly, we have shown that ST3 expression is also correlated with cell death and migration during frog metamorphosis (22, 24) . These expression profiles makes ST3 unique among different MMPs.
Another property that separates ST3 from most other MMPs is its secretion directly in the mature enzyme form instead of the inactive proenzyme form, as for most other MMPs (40) . On the other hand, its substrate in the ECM, if any, is unknown at the present time.
Like its unique expression and function, the ST3 gene also has a quite distinct organization compared with other MMPs. It has only eight instead of ten exons, as in the interstitial collagenase (41, 42) and stromelysin-1 (43) genes, 13 exons, as in gelatinases (44) (45) (46) , due to the presence of the fibronectin-like repeats, or only six exons, as in matrilysin (47), due to the lack of the carboxyl hemopexin domain (not shown). All these other MMPs share similar intron-exon boundaries.
However, like these other MMPs, the first exon of ST3 encodes the prepeptide and part of the propeptide and the second exon encodes the remaining propeptide and part of the catalytic domain (Fig. 1) . The catalytic domain of ST3 is encoded by four exons, like most other MMPs. Unlike the other MMP genes, the fourth exon of the catalytic domain is larger and includes part of the carboxyl hemopexin domain. The rest of the hemopexin domain is encoded by only three instead of five additional exons, with different boundaries compared with the corresponding ones in other MMPs ( Fig. 1 and data not shown) . Finally, this structure is conserved during evolution, as the human ST3 gene has been reported to have an identical structure to Xenopus ST3 (48) . These results suggest that ST3 has evolved from a progenitor gene before the evolution of the other MMP genes. This evolutionary divergence may also account for the distinct expression and properties of ST3 compared with the other MMPs.
Transcription of the Xenopus ST3 gene initiates from two start sites
To determine the 5′-end of the Xenopus ST3 mRNA, we previously used anchor PCR to clone the 5′-end of ST3 mRNA (24; Shi,Y.-B.,unpublished observations). This resulted in the isolation of eight cDNA clones with the 5′-end at the +1 position and seven additional clones with their 5′-end located between -62 and -4. In addition, the original λ cDNA clone had the 5′-end at -27. These results suggest the existence of more than one start site. Our primer extension results here directly demonstrate the presence of two start sites, the minor one at +1 and the major one at -94.
Functional evidence for the presence of two start sites comes from our transfection studies in tissue culture cells. Deletion of the region encompassing either transcription start site had little effect on the promoter activity, while deletions removing both start sites abolished promoter function. Thus, although our current transfection assay does not allow us to determine whether and how the two start sites are differentially used in vivo, our results show that at least one of the start sites is required for transcription from the ST3 gene.
Mutations of the putative TATA boxes had little effect on the ST3 promoter. Thus, the ST3 promoter belongs to the class of RNA polymerase II promoters that require the presence of an initiator (49, 50) , which explains the requirement for at least one start site for promoter function. Unfortunately, initiator sequences differ widely in different genes and it is difficult to determine the mechanism of initiator action through routine mutational and transfection studies. On the other hand, it is generally believed that initiators, like TATA boxes, help to recruit basal transcription machinery in the presence of other transcription activators and to direct accurate transcription from the start site (49, 50) .
Mechanism of transcriptional regulation of the ST3 gene
Both the frog and mammalian ST3 genes are temporally and spatially regulated. The genes are specifically expressed in fibroblastic cells and tightly regulated in developmental and pathological processes. We present evidence here that GAGA or GAGA-like factors are involved in transcriptional regulation of Xenopus ST3 genes. First, multiple putative GAGA factor binding sites are present in the promoter region. Second, deletion analysis showed that all the binding sites could contribute to promoter activity. In particular, removal of the long GA repeat at -72 to -50 caused an 80% reduction in reporter activity. Finally, DNA binding experiments demonstrated the ability of at least the long GA repeat to bind to Drosophila GAGA factor and the presence of GAGA or GAGA-like factors in X.laevis.
The GAGA factors may directly recruit the basal transcription machinery to activate transcription from the promoter. Alternatively or in addition, the GAGA factor(s) could recruit a chromatin disruption or remodeling complex to the promoter to facilitate transcription from the chromatinized promoter in vivo. In this regard, the Drosophila GAGA factor has been shown to be able to bring at least one such chromation remodeling complex (NURF) to chromatinized DNA (51, 52) . The resulting energydependent chromatin remodeling may in turn allow easy access of the transcriptional machinery to the promoter.
Northern blot analyses during natural and T 3 -induced metamorphosis have implied that the ST3 gene is regulated by T 3 at the transcriptional level (24, 26) . However, we failed to observe any T 3 response of promoter constructs containing sequences up to 4000 bp upstream or 600 bp downstream of the start site. It is possible that the ST3 gene is indirectly regulated by T 3 receptors. Alternatively, the TRE is located further upstream or downstream (including in the introns or 3′-untranslated region). Thus future studies should include these other regions to determine the nature of regulation by T 3 .
It is worth pointing out that regulation of the Xenopus ST3 gene differs from mammalian MMP genes. Many mammalian MMP genes bear binding sites for transcription factor AP-1 but not GAGA factor (41) (42) (43) (44) (45) (46) (47) . The human ST3 gene promoter also differs from the Xenopus ST3 gene. It has a binding site for the retinoic acid receptor. These differences suggest that amphibian and mammalian MMP genes employ different regulation pathways to achieve similar expression profiles and serve evolutionarily conserved roles. For example, limb development is dependent on retinoic acid signaling in mammals and thyroid hormone in frogs. Thus, the mammalian ST3 gene uses a retinoic acid signal (48) while the frog ST3 gene employs a T 3 signal (24) to achieve expression of the corresponding gene during limb morphogenesis. A future challenge in the understanding of ST3 regulation will be to determine how the ST3 gene is regulated in a cell type-specific manner only during specific developmental periods using in vivo animal model systems.
